Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Marpai, Inc.

MRAINASDAQ
Healthcare
Medical - Healthcare Plans
$0.40
$-0.06(-12.44%)
U.S. Market opens in 15h 40m

Marpai, Inc. Fundamental Analysis

Marpai, Inc. (MRAI) shows moderate financial fundamentals with a PE ratio of -0.65, profit margin of -58.40%, and ROE of 39.12%. The company generates $0.0B in annual revenue with weak year-over-year growth of -24.17%.

Key Strengths

ROE39.12%
PEG Ratio-0.06

Areas of Concern

Operating Margin-54.66%
Cash Position4.89%
Current Ratio0.53
We analyze MRAI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -25.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-25.7/100

We analyze MRAI's fundamental strength across five key dimensions:

Efficiency Score

Weak

MRAI struggles to generate sufficient returns from assets.

ROA > 10%
-94.80%

Valuation Score

Excellent

MRAI trades at attractive valuation levels.

PE < 25
-0.65
PEG Ratio < 2
-0.06

Growth Score

Moderate

MRAI shows steady but slowing expansion.

Revenue Growth > 5%
-24.17%
EPS Growth > 10%
53.62%

Financial Health Score

Moderate

MRAI shows balanced financial health with some risks.

Debt/Equity < 1
-0.03
Current Ratio > 1
0.53

Profitability Score

Weak

MRAI struggles to sustain strong margins.

ROE > 15%
39.12%
Net Margin ≥ 15%
-58.40%
Positive Free Cash Flow
No

Key Financial Metrics

Is MRAI Expensive or Cheap?

P/E Ratio

MRAI trades at -0.65 times earnings. This suggests potential undervaluation.

-0.65

PEG Ratio

When adjusting for growth, MRAI's PEG of -0.06 indicates potential undervaluation.

-0.06

Price to Book

The market values Marpai, Inc. at -0.24 times its book value. This may indicate undervaluation.

-0.24

EV/EBITDA

Enterprise value stands at -0.59 times EBITDA. This is generally considered low.

-0.59

How Well Does MRAI Make Money?

Net Profit Margin

For every $100 in sales, Marpai, Inc. keeps $-58.40 as profit after all expenses.

-58.40%

Operating Margin

Core operations generate -54.66 in profit for every $100 in revenue, before interest and taxes.

-54.66%

ROE

Management delivers $39.12 in profit for every $100 of shareholder equity.

39.12%

ROA

Marpai, Inc. generates $-94.80 in profit for every $100 in assets, demonstrating efficient asset deployment.

-94.80%

Following the Money - Real Cash Generation

Operating Cash Flow

Marpai, Inc. generates limited operating cash flow of $-6.76M, signaling weaker underlying cash strength.

$-6.76M

Free Cash Flow

Marpai, Inc. generates weak or negative free cash flow of $-6.76M, restricting financial flexibility.

$-6.76M

FCF Per Share

Each share generates $-0.44 in free cash annually.

$-0.44

FCF Yield

MRAI converts -1.08% of its market value into free cash.

-1.08%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.65

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.24

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.34

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.53

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.39

vs 25 benchmark

ROA

Return on assets percentage

-0.95

vs 25 benchmark

ROCE

Return on capital employed

1.13

vs 25 benchmark

How MRAI Stacks Against Its Sector Peers

MetricMRAI ValueSector AveragePerformance
P/E Ratio-0.6529.43 Better (Cheaper)
ROE39.12%800.00% Weak
Net Margin-58.40%-20145.00% (disorted) Weak
Debt/Equity-0.030.30 Strong (Low Leverage)
Current Ratio0.534.64 Weak Liquidity
ROA-94.80%-17936.00% (disorted) Weak

MRAI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Marpai, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-477.03%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-656.53%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ